LeMaitre Vascular, Inc. (LMAT) is a publicly traded Healthcare sector company. As of July 14, 2026, LMAT trades at $97.94 with a market cap of $2.29B and a P/E ratio of 35.79. LMAT moved -2.50% today. Year to date, LMAT is +20.67%; over the trailing twelve months it is +16.38%. Its 52-week range spans $71.42 to $118.01. Analyst consensus is buy with an average price target of $123.00. Rallies surfaces LMAT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
LeMaitre Vascular, Inc. (LMAT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. LMAT moved -2.50% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $97.94 |
| Market Cap | $2.29B |
| P/E Ratio | 35.79 |
| EPS | $2.76 |
| Dividend Yield | 0.25% |
| 52-Week High | $118.01 |
| 52-Week Low | $71.42 |
| Volume | 192.04K |
| Avg Volume | 0 |
| Revenue (TTM) | $256.28M |
| Net Income | $62.40M |
| Gross Margin | 72.39% |
7 analysts cover LMAT: 0 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $123.00.